par Spasovski, Goce;Vanholder, Raymond;Allolio, Bruno;Annane, Djillali;Ball, Steve;Bichet, Daniel D.G.;Decaux, Guy
;Fenske, Wiebke;Hoorn, Ewout E.J.;Ichai, Carole;Joannidis, Michael;Soupart, Alain
;Zietse, Robert;Haller, Maria;Nagler, Evi;van Biesen, Wim;Van Der Veer, Sabine
Référence BANTAO Journal, 12, 2, page (63-72)
Publication Publié, 2014


Référence BANTAO Journal, 12, 2, page (63-72)
Publication Publié, 2014
Article révisé par les pairs
Résumé : | Hyponatraemia, defined as a serum sodium concentration <135 mmol/l, is the most common disorder of body fuid and electrolyte balance encountered in clinical practice. It can lead to a wide spectrum of clinical symptoms, from subtle to severe or even life threatening, and is associated with increased mortality, morbidity and length of hospital stay in patients presenting with a range of conditions. Despite this, the management of patients remains problematic. The prevalence of hyponatraemia in widely different conditions and the fact that hyponatraemia is managed by clinicians with a broad variety of backgrounds have fostered diverse institution-and speciality-based approaches to diagnosis and treatment. To obtain a common and holistic view, the European Society of Intensive Care Medicine (ESICM), the European Society of Endocrinology (ESE) and the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA), represented by European Renal Best Practice (ERBP), have developed the Clinical Practice Guideline on the diagnostic approach and treatment of hyponatraemia as a joint venture of three societies representing specialists with a natural interest in hyponatraemia. In addition to a rigorous approach to methodology and evaluation, we were keen to ensure that the document focused on patient-important outcomes and included utility for clinicians involved in everyday practice. |